The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation

N. Leung, A. Shaikh, Fernando G Cosio, M. D. Griffin, Stephen C Textor, J. M. Gloor, T. R. Schwab, T. S. Larson, P. G. Dean, M. Prieto, Scott Nyberg, Mark D Stegall, C. U. Lee, M. R. Pittelkow

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Nephrogenic systemic fibrosis (NSF) is a debilitating disease in patients with severely diminished kidney function. Currently, no standard treatment exists but improvement has been reported after restoration of kidney function. We retrospectively studied 17 NSF patients with and without successful kidney transplantation (KTx) to evaluate the effects of KTx on NSF. Nine of the 11 KTx developed NSF pretransplant whereas two developed NSF immediately after KTx with delayed graft function. Two of the six dialysis patients had previous failed kidney transplants. Age and sex were well matched. All but one patient was dialysis dependent at the time of NSF. Median follow-up was 35 months for KTx patients and 9 months for dialysis patients. Kidney transplants achieved adequate renal function with median serum creatinine of 1.4 (0.9-2.8) mg/dL and a glomerular filtration rate of 42 (19-60) mL/min/1.73 m2. NSF improved in 54.6% of the transplanted patients and 50% of the nontransplanted patients (p = 0.86). Two KTx patients had complete resolution of their symptoms whereas four had partial improvement. Improvement in the dialysis patients was all partial. Successful KTx did not insure improvement in NSF and in fact appeared to have no significant benefit over dialysis.

Original languageEnglish (US)
Pages (from-to)558-562
Number of pages5
JournalAmerican Journal of Transplantation
Volume10
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Nephrogenic Fibrosing Dermopathy
Kidney Transplantation
Dialysis
Kidney
Delayed Graft Function
Transplants
Glomerular Filtration Rate
Creatinine

Keywords

  • Dermatology
  • Kidney transplantation
  • Skin
  • Thymoglobulin

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. / Leung, N.; Shaikh, A.; Cosio, Fernando G; Griffin, M. D.; Textor, Stephen C; Gloor, J. M.; Schwab, T. R.; Larson, T. S.; Dean, P. G.; Prieto, M.; Nyberg, Scott; Stegall, Mark D; Lee, C. U.; Pittelkow, M. R.

In: American Journal of Transplantation, Vol. 10, No. 3, 03.2010, p. 558-562.

Research output: Contribution to journalArticle

Leung, N, Shaikh, A, Cosio, FG, Griffin, MD, Textor, SC, Gloor, JM, Schwab, TR, Larson, TS, Dean, PG, Prieto, M, Nyberg, S, Stegall, MD, Lee, CU & Pittelkow, MR 2010, 'The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation', American Journal of Transplantation, vol. 10, no. 3, pp. 558-562. https://doi.org/10.1111/j.1600-6143.2009.02959.x
Leung, N. ; Shaikh, A. ; Cosio, Fernando G ; Griffin, M. D. ; Textor, Stephen C ; Gloor, J. M. ; Schwab, T. R. ; Larson, T. S. ; Dean, P. G. ; Prieto, M. ; Nyberg, Scott ; Stegall, Mark D ; Lee, C. U. ; Pittelkow, M. R. / The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. In: American Journal of Transplantation. 2010 ; Vol. 10, No. 3. pp. 558-562.
@article{9dae16850a4641d9b31a10ef5dbce2bc,
title = "The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation",
abstract = "Nephrogenic systemic fibrosis (NSF) is a debilitating disease in patients with severely diminished kidney function. Currently, no standard treatment exists but improvement has been reported after restoration of kidney function. We retrospectively studied 17 NSF patients with and without successful kidney transplantation (KTx) to evaluate the effects of KTx on NSF. Nine of the 11 KTx developed NSF pretransplant whereas two developed NSF immediately after KTx with delayed graft function. Two of the six dialysis patients had previous failed kidney transplants. Age and sex were well matched. All but one patient was dialysis dependent at the time of NSF. Median follow-up was 35 months for KTx patients and 9 months for dialysis patients. Kidney transplants achieved adequate renal function with median serum creatinine of 1.4 (0.9-2.8) mg/dL and a glomerular filtration rate of 42 (19-60) mL/min/1.73 m2. NSF improved in 54.6{\%} of the transplanted patients and 50{\%} of the nontransplanted patients (p = 0.86). Two KTx patients had complete resolution of their symptoms whereas four had partial improvement. Improvement in the dialysis patients was all partial. Successful KTx did not insure improvement in NSF and in fact appeared to have no significant benefit over dialysis.",
keywords = "Dermatology, Kidney transplantation, Skin, Thymoglobulin",
author = "N. Leung and A. Shaikh and Cosio, {Fernando G} and Griffin, {M. D.} and Textor, {Stephen C} and Gloor, {J. M.} and Schwab, {T. R.} and Larson, {T. S.} and Dean, {P. G.} and M. Prieto and Scott Nyberg and Stegall, {Mark D} and Lee, {C. U.} and Pittelkow, {M. R.}",
year = "2010",
month = "3",
doi = "10.1111/j.1600-6143.2009.02959.x",
language = "English (US)",
volume = "10",
pages = "558--562",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation

AU - Leung, N.

AU - Shaikh, A.

AU - Cosio, Fernando G

AU - Griffin, M. D.

AU - Textor, Stephen C

AU - Gloor, J. M.

AU - Schwab, T. R.

AU - Larson, T. S.

AU - Dean, P. G.

AU - Prieto, M.

AU - Nyberg, Scott

AU - Stegall, Mark D

AU - Lee, C. U.

AU - Pittelkow, M. R.

PY - 2010/3

Y1 - 2010/3

N2 - Nephrogenic systemic fibrosis (NSF) is a debilitating disease in patients with severely diminished kidney function. Currently, no standard treatment exists but improvement has been reported after restoration of kidney function. We retrospectively studied 17 NSF patients with and without successful kidney transplantation (KTx) to evaluate the effects of KTx on NSF. Nine of the 11 KTx developed NSF pretransplant whereas two developed NSF immediately after KTx with delayed graft function. Two of the six dialysis patients had previous failed kidney transplants. Age and sex were well matched. All but one patient was dialysis dependent at the time of NSF. Median follow-up was 35 months for KTx patients and 9 months for dialysis patients. Kidney transplants achieved adequate renal function with median serum creatinine of 1.4 (0.9-2.8) mg/dL and a glomerular filtration rate of 42 (19-60) mL/min/1.73 m2. NSF improved in 54.6% of the transplanted patients and 50% of the nontransplanted patients (p = 0.86). Two KTx patients had complete resolution of their symptoms whereas four had partial improvement. Improvement in the dialysis patients was all partial. Successful KTx did not insure improvement in NSF and in fact appeared to have no significant benefit over dialysis.

AB - Nephrogenic systemic fibrosis (NSF) is a debilitating disease in patients with severely diminished kidney function. Currently, no standard treatment exists but improvement has been reported after restoration of kidney function. We retrospectively studied 17 NSF patients with and without successful kidney transplantation (KTx) to evaluate the effects of KTx on NSF. Nine of the 11 KTx developed NSF pretransplant whereas two developed NSF immediately after KTx with delayed graft function. Two of the six dialysis patients had previous failed kidney transplants. Age and sex were well matched. All but one patient was dialysis dependent at the time of NSF. Median follow-up was 35 months for KTx patients and 9 months for dialysis patients. Kidney transplants achieved adequate renal function with median serum creatinine of 1.4 (0.9-2.8) mg/dL and a glomerular filtration rate of 42 (19-60) mL/min/1.73 m2. NSF improved in 54.6% of the transplanted patients and 50% of the nontransplanted patients (p = 0.86). Two KTx patients had complete resolution of their symptoms whereas four had partial improvement. Improvement in the dialysis patients was all partial. Successful KTx did not insure improvement in NSF and in fact appeared to have no significant benefit over dialysis.

KW - Dermatology

KW - Kidney transplantation

KW - Skin

KW - Thymoglobulin

UR - http://www.scopus.com/inward/record.url?scp=76949099890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76949099890&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2009.02959.x

DO - 10.1111/j.1600-6143.2009.02959.x

M3 - Article

VL - 10

SP - 558

EP - 562

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 3

ER -